Kore Private Wealth’s Rein Therapeutics RNTX Stock Holding History

Kore Private Wealth’s Portfolio RNTX Stock Details RNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$2K	Hold	559	–	–	﹤0.01%	261
2022 Q2	$3K	Hold	559	–	–	﹤0.01%	308
2022 Q1	$6K	Hold	559	–	–	﹤0.01%	319
2021 Q4	$6K	Hold	559	–	–	﹤0.01%	305
2021 Q3	$11K	Hold	559	–	–	﹤0.01%	448
2021 Q2	$14K	Hold	559	–	–	﹤0.01%	425
2021 Q1	$16K	Hold	559	–	–	﹤0.01%	369
2020 Q4	$12K	Hold	559	–	–	﹤0.01%	335
2020 Q3	$14K	Hold	559	–	–	﹤0.01%	273
2020 Q2	$13K	Hold	559	–	–	﹤0.01%	741
2020 Q1	$4K	Hold	559	–	–	﹤0.01%	858
2019 Q4	$6K	Hold	559	–	–	﹤0.01%	844
2019 Q3	$5K	Hold	559	–	–	﹤0.01%	228
2019 Q2	$8K	Hold	559	–	–	﹤0.01%	228
2019 Q1	$22K	Hold	559	–	–	0.01%	501
2018 Q4	$9K	Buy	+559	New	+$22.5K	﹤0.01%	586

Other funds holding RNTX

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kore Private Wealth's RNTX Position: Q3 2022 in Review

Kore Private Wealth held its Rein Therapeutics (RNTX) position steady in Q3 2022 at 559 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #261.

Kore Private Wealth first reported a position in RNTX in Q4 2018 and has held it in 16 quarters since. The position peaked at $22K in Q1 2019. 33 funds tracked by Wall St. Rank hold RNTX as of Q3 2022.

Kore Private Wealth held 559 shares of Rein Therapeutics worth $2K as of Q3 2022.
Kore Private Wealth left its Rein Therapeutics share count unchanged in Q3 2022.
Rein Therapeutics made up ﹤0.01% of Kore Private Wealth's portfolio in Q3 2022, its #261 holding.
Kore Private Wealth first reported a position in Rein Therapeutics in Q4 2018 and has held it in 16 quarters since.
Kore Private Wealth's Rein Therapeutics position peaked at $22K in Q1 2019.
33 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2022.

Based on Kore Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.